New York – Global law firm Reed Smith today announced that it recently advised EW Healthcare Partners on its $90 million private investment into the public equity of MiMedx Group, Inc. (MDXG: OTC US), an industry leader in advanced wound care and an emerging therapeutic biologics company. EW purchased convertible preferred stock from the company. The investment included a global refinancing of the company that included a new credit facility.
The Reed Smith team included New York-based partners Mark Pedretti, Jared Kelly, and Tadashi Okamoto and Dallas-based associates Katherine Geddes and Brooke Dorris.
About Reed Smith
Reed Smith is a dynamic international law firm dedicated to helping clients move their businesses forward. Our belief is that by delivering smarter and more creative legal services, we will not only enrich our clients’ experiences with us, but also support them in achieving their business goals.
Our long-standing relationships, international outlook, and collaborative structure make us the go-to partner for the speedy resolution of complex disputes, transactions, and regulatory matters.
For further information, please visit reedsmith.com.